Showing results (401-410 of 21,757) with videos related to
Sort By:
Pageof 2,176
British Journal of Cancer|July 1, 2015
Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancerA J Weickhardt, D S Williams, C K Lee, et al.British Journal of Cancer|July 1, 2015
Family history of cancer and the risk of squamous cell carcinoma of oesophagus: a case-control study in Kashmir, IndiaG A Bhat, I A Shah, R Rafiq, et al.British Journal of Cancer|July 1, 2015
Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumourJ K Pine, E Morris, G G Hutchins, et al.British Journal of Cancer|August 28, 2025
Primary tumor sidedness and negative hyperselection to modulate anti-EGFR-based maintenance strategies in patients with RAS wild-type metastatic colorectal cancer: individual patient data pooled analysis of two randomized clinical trialsAlexej Ballhausen, Federica Morano, Arndt Stahler, et al.British Journal of Cancer|August 30, 2025
Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physiciansElie Rassy, Suzette Delaloge, Yannis Slaouti, et al.British Journal of Cancer|September 1, 2025
Systemic activation of NRF2 contributes to the therapeutic efficacy of clinically-approved KRAS-G12C anti-cancer drugsLiam Baird, Lin Zhang, Takanori Hidaka, et al.British Journal of Cancer|July 29, 2016
Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?Michael E Jones, Minouk J Schoemaker, Lauren Wright, et al.British Journal of Cancer|August 3, 2016
Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot StudyNamrata Vijayvergia, Patrick M Boland, Elizabeth Handorf, et al.British Journal of Cancer|August 3, 2016
Evaluating the risk of ovarian cancer before surgery using the ADNEX model: a multicentre external validation studyA Sayasneh, L Ferrara, B De Cock, et al.British Journal of Cancer|August 3, 2016
De novo post-diagnosis statin use, breast cancer-specific and overall mortality in women with stage I-III breast cancerAmelia Smith, Laura Murphy, Linda Sharp, et al.Pageof 2,176